世界のフローサイトメトリー市場動向（～2018）...市場調査レポートについてご紹介

TABLE OF CONTENTS

1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 REPORT DESCRIPTION
1.3 MARKETS COVERED
1.4 STAKEHOLDERS
1.5 MARKET SCOPE
1.6 RESEARCH METHODOLOGY
1.6.1 MARKET SIZE ESTIMATION
1.6.2 MARKET BREAKDOWN & DATA TRIANGULATION
1.6.3 MARKET SHARE ESTIMATION
1.6.4 KEY DATA FROM SECONDARY SOURCES
1.6.5 KEY DATA FROM PRIMARY SOURCES
1.6.6 ASSUMPTIONS

2 EXECUTIVE SUMMARY

3 PREMIUM INSIGHTS
3.1 GLOBAL FLOW CYTOMETRY MARKET, BY GEOGRAPHY
3.2 GLOBAL FLOW CYTOMETRY MARKET, BY SEGMENT
3.3 GLOBAL FLOW CYTOMETRY MARKET, BY APPLICATION
3.4 COMPETITIVE ANALYSIS: GLOBAL FLOW CYTOMETRY MARKET

4 MARKET OVERVIEW
4.1 INTRODUCTION
4.2 EVOLUTION
4.3 MARKET SEGMENTATION
4.3.1 FLOW CYTOMETRY MARKET, BY TECHNOLOGY
4.3.2 FLOW CYTOMETRY MARKET, BY PRODUCTS & SERVICES
4.3.3 FLOW CYTOMETRY MARKET, BY END-USERS
4.3.4 FLOW CYTOMETRY MARKET, BY APPLICATION
4.4 MARKET DYNAMICS
4.4.1 MARKET DRIVERS
4.4.1.1 Technological advancements in flow cytometry instruments
4.4.1.2 Fostering use of flow cytometry techniques in research activities
4.4.1.3 Increasing use of flow cytometry in clinical trials
4.4.1.4 Increasing use of flow cytometry in HIV and cancer research
4.4.1.5 Launch of new reagents for specific applications like diagnostics and drug discovery.
4.4.1.6 Development of user-friendly and intuitive software
4.4.2 RESTRAINTS
4.4.2.1 High cost of instruments
4.4.2.2 Reluctance among researchers to use flow cytometery in emerging countries
4.4.2.3 Lack of awareness and dearth of training
4.4.3 CHALLENGES
4.4.3.1 Lack of proper infrastructure for conducting research activities in emerging countries
4.4.3.2 Complexities related to reagent development
4.4.4 OPPORTUNITIES
4.4.4.1 Emerging markets unfolds new opportunities
4.4.4.2 Development of mass cytometry and combination of cell- and bead-based flow cytometry technologies
4.4.4.3 Fostering stem cell research
4.4.4.4 Evolution of high-throughput flow cytometry

5 INDUSTRY TRENDS
5.1 INTRODUCTION
5.2 SUPPLY CHAIN ANALYSIS
5.3 INDUSTRY TRENDS
5.3.1 DEVELOPMENT OF MULTICOLOR FLOW CYTOMETRY
5.3.2 TECHNOLOGY ADVANCEMENTS INCREASING ADOPTION
5.3.3 INTEGRATION OF BASIC FLOW CYTOMETRY TECHNIQUES IN MODERN HEMATOLOGY ANALYZERS
5.4 BURNING ISSUES
5.4.1 REGULATORY CHALLENGES
5.4.1.1 Challenging Food and Drug Administration (FDA) requirements
5.4.1.2 Stringent Analyte Specific Reagent (ASR) Rule
5.4.1.3 Validation challenges for cell-based instruments
5.4.1.4 Dearth of laboratory-developed test (LDT) Guidelines on Cell-based Fluorescence assays
5.4.1.5 Changing regulatory environment
5.4.2 REIMBURSEMENT ISSUES
5.5 WINNING IMPERATIVES
5.5.1 STRATEGY OF DIVERSIFICATION OF PRODUCT PORTFOLIO
5.5.2 STRATEGY OF GEOGRAPHIC EXPANSIONS IN EMERGING MARKETS
5.5.3 STRATEGY FOR THE DEVELOPMENT OF SPECIFIC REAGENTS
5.5.4 PORTER’S FIVE FORCES ANALYSIS
5.5.4.1 Threat from new entrants
5.5.4.2 Threat from substitutes
5.5.4.3 Bargaining power of suppliers
5.5.4.4 Bargaining power of buyers
5.5.4.5 Intensity of competitive rivalry

6 GLOBAL FLOW CYTOMETRY MARKET, BY TECHNOLOGY
6.1 INTRODUCTION
6.2 CELL-BASED FLOW CYTOMETRY
6.3 BEAD-BASED FLOW CYTOMETRY
6.4 OTHERS

7 GLOBAL FLOW CYTOMETRY MARKET, BY PRODUCT
7.1 INTRODUCTION
7.2 FLOW CYTOMETRY INSTRUMENTS
7.3 REAGENTS AND CONSUMABLES
7.4 SOFTWARE
7.5 SERVICES
7.6 ACCESSORIES

8 FLOW CYTOMETRY MARKET, BY APPLICATION
8.1 INTRODUCTION
8.2 RESEARCH
8.2.1 PHARMACEUTICAL
8.2.1.1 Drug Discovery
8.2.1.2 Stem cell research
8.2.1.3 In vitro toxicity testing
8.2.2 APOPTOSIS
8.2.3 CELL CYCLE ANALYSIS
8.2.4 CELL SORTING
8.2.5 CELL VIABILITY
8.2.6 IMMUNOLOGY
8.2.7 OTHERS
8.3 CLINICAL APPLICATIONS
8.3.1 ORGAN TRANSPLANTATION
8.3.2 CANCER
8.3.3 IMMUNODEFICIENCY DISEASES
8.3.4 HEMATOLOGY
8.3.5 OTHERS
8.4 INDUSTRIAL APPLICATIONS

9 FLOW CYTOMETRY MARKET, BY END USER
9.1 INTRODUCTION
9.2 COMMERCIAL ORGANIZATIONS
9.3 HOSPITALS
9.4 ACADEMIC INSTITUTES
9.5 MEDICAL SCHOOLS
9.6 CLINICAL TESTING LABS

10 GLOBAL FLOW CYTOMETRY MARKET, BY GEOGRAPHY
10.1 INTRODUCTION
10.2 NORTH AMERICA
10.2.1 U.S.
10.2.2 CANADA
10.3 EUROPE
10.3.1 U.K.
10.3.2 GERMANY
10.3.3 FRANCE
10.3.4 REST OF EUROPE
10.4 ASIA-PACIFIC
10.4.1 JAPAN
10.4.2 CHINA
10.4.3 INDIA
10.4.4 REST OF ASIA-PACIFIC
10.4.5 REST OF THE WORLD (ROW)

11 COMPETITIVE LANDSCAPE
11.1 INTRODUCTION
11.1.1 OVERVIEW
11.1.2 MARKET SHARE ANALYSIS, FLOW CYTOMETRY MARKET
11.2 COMPETITIVE SITUATION & TRENDS
11.2.1 NEW PRODUCT LAUNCHES
11.2.2 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS, & JOINT VENTURES
11.2.3 MERGERS & ACQUISITIONS
11.2.4 EXPANSIONS
11.2.5 OTHER DEVELOPMENTS

12 COMPANY PROFILES
12.1 BECTON, DICKINSON AND COMPANY
12.2 BECKMAN COULTER, INC. (A SUBSIDIARY OF DANAHER CORPORATION)
12.3 BIO-RAD LABORATORIES, INC.
12.4 EBIOSCIENCE, INC. (A SUBSIDIARY OF AFFYMETRIX, INC.)
12.5 EMD MILLIPORE CORPORATION (A DIVISION OF MERCK KGAA)
12.6 LIFE TECHNOLOGIES CORPORATION (A BRAND OF THERMO FISHER SCIENTIFIC, INC.)
12.7 LUMINEX CORPORATION
12.8 MILTENYI BIOTECH
12.9 PARTEC GMBH
12.10 TTP LABTECH LTD.

*Details on Business Overview, Products & Services, Key Strategy, and Recent Developments might not be captured in case of unlisted companies.